Summary: Eli Lilly and Quintiles entered into a co-investment partnership to develop a new solution using computer-assisted designs that emphasize the improvement of scientific and operational outcomes of clinical trials. The results were shared at the DPharm 2013 event and project leaders from both companies will talk to our host Craig Lipset on how this formation is doing a year later. Also joining Craig is Jeff Lee, CEO, Omniscience to discuss featured news and trends in clinical trial innovation and in particular mobile applications. Host: Craig Lipset, MBA, Head of Clinical Innovation, R&D, Pfizer, Inc. Guests: Jeffrey Kasher, PhD, VP & COO, Eli Lilly & Company Jeff Lee, CEO, Omniscience Mobile Rick Sax, MD, SVP Clinical Design & Reporting Services, Quintiles
